<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000560649"><TermName>11C topotecan</TermName><TermPronunciation>(... toh-poh-TEE-kan)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of certain types of cancer, including ovarian cancer and lung cancer. 11C topotecan is a radioactive form of the anticancer drug topotecan. It builds up in tumor tissues and is detected by positron emission tomography (PET). It may be used to help determine whether treatment with topotecan will work. It is a type of topoisomerase I inhibitor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000721081" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;11C topotecan&quot;" language="en" id="_3"/><MediaLink ref="CDR0000721082" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;topotecán 11C&quot;" language="es" id="_4"/><SpanishTermName>topotecán 11C</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de ciertos tipos de cáncer, como el cáncer de ovario y el cáncer de pulmón. El topotecán 11C es una forma radiactiva del medicamento anticanceroso topotecán. Se acumula en los tejidos tumorales y se detecta mediante una exploración con tomografía por emisión de positrones (TEP). Se puede usar para ayudar a determinar si el tratamiento con topotecán será eficaz. Es un tipo de inhibidor de la topoisomerasa I.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-03-06</DateFirstPublished></GlossaryTerm>
